Triple

T23517019
Position Surface form Disambiguated ID Type / Status
Subject Central Drugs Standard Control Organisation E574393 entity
Predicate hasPart P35 FINISHED
Object Drugs Controller General of India office
The Drugs Controller General of India office is the national regulatory authority responsible for approving and overseeing the safety, efficacy, and quality of drugs and certain medical products in India.
E574393 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Drugs Controller General of India office | Statement: [Central Drugs Standard Control Organisation, hasPart, Drugs Controller General of India office]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Drugs Controller General of India office
Context triple: [Central Drugs Standard Control Organisation, hasPart, Drugs Controller General of India office]
  • A. Central Drugs Standard Control Organisation
    The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
  • B. Drug Supervisory Body
    The Drug Supervisory Body was an international oversight organization established under the League of Nations to monitor and regulate the global trade and production of narcotic drugs.
  • C. National Agency for Food and Drug Administration and Control
    The National Agency for Food and Drug Administration and Control is Nigeria’s federal regulatory body responsible for overseeing the safety, quality, and standardization of food, drugs, cosmetics, medical devices, and related products.
  • D. Bureau of Controlled Drugs (Taiwan)
    The Bureau of Controlled Drugs (Taiwan) is a government agency responsible for regulating, monitoring, and enforcing laws related to narcotics and other controlled substances in Taiwan.
  • E. Intercantonal Office for the Control of Medicines
    The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Drugs Controller General of India office
Triple: [Central Drugs Standard Control Organisation, hasPart, Drugs Controller General of India office]
Generated description
The Drugs Controller General of India office is the national regulatory authority responsible for approving and overseeing the safety, efficacy, and quality of drugs and certain medical products in India.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Drugs Controller General of India office
Target entity description: The Drugs Controller General of India office is the national regulatory authority responsible for approving and overseeing the safety, efficacy, and quality of drugs and certain medical products in India.
  • A. Central Drugs Standard Control Organisation chosen
    The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
  • B. Drug Supervisory Body
    The Drug Supervisory Body was an international oversight organization established under the League of Nations to monitor and regulate the global trade and production of narcotic drugs.
  • C. National Agency for Food and Drug Administration and Control
    The National Agency for Food and Drug Administration and Control is Nigeria’s federal regulatory body responsible for overseeing the safety, quality, and standardization of food, drugs, cosmetics, medical devices, and related products.
  • D. Bureau of Controlled Drugs (Taiwan)
    The Bureau of Controlled Drugs (Taiwan) is a government agency responsible for regulating, monitoring, and enforcing laws related to narcotics and other controlled substances in Taiwan.
  • E. Intercantonal Office for the Control of Medicines
    The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e245bb3dcc8190ba9a2b35972b58d0 completed April 17, 2026, 2:37 p.m.
NER Named-entity recognition batch_69f1aa82a8448190bf7ad56137c5eb94 completed April 29, 2026, 6:51 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0cdf4acf7081909ea152eb4a634bab completed May 19, 2026, 10:08 p.m.
NEDg Description generation batch_6a0ce210d8108190a6338389fcefb5a4 completed May 19, 2026, 10:20 p.m.
NED2 Entity disambiguation (via description) batch_6a0ce2bffdd8819081ef20b90bc0ae7b completed May 19, 2026, 10:22 p.m.
Created at: April 17, 2026, 6:08 p.m.